News

Dexcom has released a new AI-powered photo meal logging feature to Stelo, the first over-the-counter glucose biosensor cleared by the Food and Drug Administration in the United States.
DexCom, Inc., the global leader in glucose biosensing, announced today it has released a new AI-powered photo meal logging ...
Stelo, the first FDA-cleared over-the-counter glucose biosensor, joins the G7 continuous glucose monitor (CGM) in offering ...
DexCom Q2 results are likely to reflect strong growth on the back of coverage by two large PBMs and Stelo traction, driving momentum and market expansion in 2025.
Dexcom is recalling certain Dexcom G6, G7, ONE, and ONE+ glucose monitoring receivers because of a problem with the speaker that may cause it to fail to make an alert sound when blood sugar is dangero ...
Dexcom's growth in sensors and U.S. expansion is solid, but slowing revenue growth and high valuation limit upside. Click ...
Dexcom is recalling 19 models of its continuous glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels. The affected devices are models ...
The recall affects Dexcom G6, G7, ONE, and ONE+ continuous glucose monitor receivers but not the smartphone apps or insulin ...
UT track star Clarke Byram is making history as the newest member of the Dexcom U roster. It is the first and only NIL program created exclusively for college athletes with diabetes.
Note that some links may require registration or subscription. A New York man who entered an MRI room while a scan was taking ...
Dexcom (Nasdaq:DXCM) has issued an update related to a recall for its continuous glucose monitor (CGM) components.
FDA recalls Dexcom glucose monitors (G6, G7, ONE models) due to alert issues posing severe health risks. Read more here.